Clinical Trial: ALLIANCE A032103

ALLIANCE A032103

Status: New, Open

MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer

Eligible for screening study DCP 001